Slides and Webcasts from all ESMO Advanced Courses are reserved to ESMO Members and registered participants, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.
ESMO Advanced Course on PARP Inhibition: Therapeutic Applications in Oncology 2024: Barcelona
- Start date
- 29 Oct 2024
- End date
- 30 Oct 2024
- Location
- Barcelona, Spain
Learning objectives
- To get an overview on transversal thematic for dedicated pathway to improve competencies
- To understand the basics of DNA repair machinery and the role of PARP
- To share knowledge by experts from organ specific experiences
- To cross compare clinical experience and safety of PARPi in different tumour types
- To understand the mechanisms of resistance and how they are similar or differ among various models
- To learn about the development of PARP inhibition in cancer treatment
- To learn about experiences from each other to improve knowledge in the field of PARPi use and development
- To identify the challenges of PARP inhibition: Overcoming PARPi resistance and future research
Co-Chairs
- Elena Castro, Spain
- Isabelle Ray-Coquard, France
Travel grant
In addition to the course registration and the hotel accommodation, a travel grant of maximum 600 euros is offered to non-local participants as a contribution versus their travel costs (excluding Visa costs).
Participants must supply proof of travel as appropriate (tickets and receipts/invoices).
The reimbursement will be processed after the course according to the rules below:
Distance |
Reimbursement per return trip |
|---|---|
Up to 100 km |
EUR 70.00 |
101 > 399 km |
EUR 150.00 |
> 400 km |
Please visit this page and use the rail or flight calculator by inserting the city of departure and the city of arrival; then refer to Table 2 (on the same page) to check the reimbursement amount corresponding to the calculated distance. |
*Place of work | |
Accreditation
The programme of this event has been accredited with 11 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Supported by
